Aviva
STN icon

Aviva’s Stantec STN Stock Holding History

Aviva’s Portfolio STN Stock Details STN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.58M Sell
95,499
-2,862
-3% -$231K 0.01% 573
2026
Q1 		$8.48M Buy
98,361
+2,115
+2% +$199K 0.01% 557
2025
Q4 		$9.09M Buy
96,246
+5,417
+6% +$558K 0.02% 561
2025
Q3 		$9.79M Buy
90,829
+10,320
+13% +$1.13M 0.02% 534
2025
Q2 		$8.76M Buy
80,509
+6,468
+9% +$623K 0.02% 536
2025
Q1 		$6.14M Buy
74,041
+9,813
+15% +$785K 0.01% 518
2024
Q4 		$5.03M Buy
+64,228
New +$5.33M 0.01% 535

Other funds holding STN

Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Aviva's STN Position: Q2 2026 in Review

Aviva reduced its Stantec (STN) stake by 2.9% in Q2 2026, selling an estimated $231K and leaving 95,499 shares worth $6.58M. The position accounts for 0.01% of the portfolio, ranked #573.

Aviva first reported a position in STN in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.79M in Q3 2025. 291 funds tracked by Wall St. Rank hold STN as of Q2 2026.

  • Aviva held 95,499 shares of Stantec worth $6.58M as of Q2 2026.
  • Aviva sold 2,862 Stantec shares in Q2 2026, an estimated $231K.
  • Stantec made up 0.01% of Aviva's portfolio in Q2 2026, its #573 holding.
  • Aviva first reported a position in Stantec in Q4 2024 and has held it in 7 quarters since.
  • Aviva's Stantec position peaked at $9.79M in Q3 2025.
  • 291 funds tracked by Wall St. Rank held Stantec as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.